Endoscope Reprocessing Market – Global Outlook & Forecast 2022-2027
Description
Endoscope Reprocessing Market – Global Outlook & Forecast 2022-2027
The global endoscope reprocessing market is expected to grow at a CAGR of 8.37% during 2022-2027.
Endoscope reprocessing is a multi-step process that involves effective cleaning, disinfection, and sterilization of endoscopy devices and their accessories. The high risk of infections associated with improper sterilization of endoscopes is majorly driving the demand for reprocessing equipment. The endoscope reprocessing market will be flourishing due to a focus on high cleaning standards and mounting pressures for sterilized and disinfected medical devices in hospitals and clinics.
The high usage of endoscopic devices mainly drives the global endoscope reprocessing market for diagnosis and treatment. This is due to the growing burden of various digestive and respiratory tract disorders that require endoscopy. Frequent use of these endoscopic instruments leads to an increased risk of infections; hence, these are being disinfected and cleaned using reprocessing systems. The demand for these systems is likely to grow in healthcare centers, but however, the high cost of endoscopy, improper or under reprocessing leading to infections, and the growing prominence of single-use bio processors can hinder the growth of the market.
Gastrointestinal (GI) endoscopy is an essential tool for identifying and treating gastrointestinal tract disorders. Gastrointestinal endoscopes can become highly contaminated with their frequent use in patients, as millions of endoscopy procedures are being performed in the US alone. Cleaning, disinfection, and sterilization process are vital for the prevention of infections caused due to the contamination of these endoscopes. Hence the demand for reprocessing the endoscopes has become highly important.
MARKET TRENDS & DRIVERS
The number of patients suffering from gastrointestinal diseases is rising across the world. These diseases are among the most costly and debilitating health conditions, accounting for about 3 million hospital admissions in the United States alone. The prevalence of these diseases is increasing the need for performing endoscopic procedures in various healthcare centers. An estimated 17 million lower GI endoscopies and about the same number of upper endoscopies are performed annually in the US. This initiates the risk of infections associated with the formation of biofilms due to their frequent usage. The infection rate approaches 1 in 10 million procedures. With the growing risk of these infections, the demand for endoscope reprocessing systems is growing.
THE GROWING TREND OF INCORPORATING TRACKING SOLUTIONS
Proper endoscope reprocessing is vital for patient safety. Ensuring that every step in the process is completed needs complex tracking and documentation. Eliminating manual documentation logs and ensuring the endoscope is disinfected and cleaned before using it in the procedure. Significant benefits of these tracking solutions include improved handling of endoscope complexity, integration with multiple systems, quality assurance of workflow, and optimization of return on investment.
TECHNOLOGICAL ADVANCEMENTS DRIVING MARKET GROWTH
Several manufacturers are emphasizing automation of the disinfection workflows to a large extent. This has also defined their production advancements and innovation strategies in recent years. For instance, in 2018, around $0.4 billion was invested by Olympus to enhance their systems for performing tests to check cleaning and disinfection effectiveness. The cleaning has always been challenging owing to the inability to inspect the cleanliness inside the lumens of an endoscope until now. The latest technological advancements have allowed the development of flexible inspection camera systems that can check an instrument's internal channels for debris and damage, which could help reduce infection rates.
HIGH COST OF ENDOSCOPY PROCEDURES AND REPROCESSING EQUIPMENT
The high cost associated with endoscopy lowers the number of endoscopic procedures performed on patients. Medical procedures such as endoscopies can be costly without insurance. The cost of a colonoscopy typically ranges between $1,250 to over $4,800 in the US, with an endoscopy's national average price of $2,750. Also, the cost of the equipment ranges from $114.07 to $280.71. The average reported repair cost—whether attributed to a leak test failure, damage during a visual inspection, or a failed cleaning verification test was estimated to be $5,833. Such high prices can limit the adoption of re-processing equipment.
IMPACT OF COVID-19 ON THE GLOBAL ENDOSCOPE REPROCESSING MARKET
Gastrointestinal complaints were frequent among COVID-19 patients, with possible occurrences of diarrhea, nausea, and vomiting. A March 2020 multicenter survey revealed near-universal exposure to COVID-19 positive patients in endoscopy units: 97.6% experienced a reduction in endoscopic activities, and 50% performed endoscopic procedures on COVID-19 positive patients. Hence, there was a moderate need for performing endoscopy procedures during COVID-19. Due to this, the demand for endoscope re-processing systems was high as there was a high risk of disease transmission among patients and healthcare providers.
MARKET SEGMENTATION
PRODUCT
In 2021, disinfectants accounted for the largest share in the global endoscope reprocessing market. The demand for disinfectants is high as there is a growing need for disinfecting endoscopes. By equipment, the market is segmented as automated endoscope reprocessors and disinfection & sterilization equipment. Automated reprocessors accounted for the highest share in the market compared to disinfection & sterilization systems as the demand for automatic reprocessing systems is proliferating owing to their advanced features and better reprocessing.
END-USER
The end-user market includes hospitals, specialty clinics & medical office suites, standalone service facilities, and others. In 2021, hospitals accounted for the highest share of the global endoscopy device cleaning market. The use of endoscopic devices is high ins hospitals as these perform an increased number of endoscopic procedures compared to other healthcare settings. However, standalone reprocessing service facilities will likely witness the fastest growth during the forecast period.
Market Segments
Product:
In 2021, North America accounted for the highest share of the global endoscope reprocessing market. Significant factors contributing to the growth of endoscope reprocessing market share in the North America region include a rise in the number of endoscopic procedures performed, high demand for sterilizing and disinfecting endoscopic devices, increasing prevalence of digestive disorders, guidelines promoting safe procedures, and technological advancements in the systems and accessories. However, the APAC region will likely witness the fastest growth during the forecast period.
North America
The global market is highly competitive, with international, regional, and local players offering a broad range of products and accessories. Leading vendors such as STERIS, Ecolab, Getinge AB, Olympus, and ASP (acquired by Fortive) are coming up with several strategies such as partnerships, collaborations, joint ventures, mergers, and acquisitions for their growth and establishment in the industry.
For instance, STERIS recently agreed to acquire Cantel Medical, a global provider of infection prevention products and services primarily to endoscopy and dental customers.
Ecolab has developed vanBaerle, offering a full range of cleaning, disinfectant, and hygiene solutions, which can contribute to Ecolab's growth in cleaning and disinfectant products.
Product launches from these vendors are advancing the global endoscope reprocessing market. For instance, in 2020, Olympus launched its OER-Elite next-generation automated endoscope reprocessing system.
Key Vendors:
1. WHAT IS THE PROJECTED MARKET SIZE & GROWTH RATE OF THE ENDOSCOPE REPROCESSING MARKET?
2. WHAT ARE THE KEY DRIVING FACTORS FOR THE GROWTH OF THE ENDOSCOPE REPROCESSING MARKET?
3. WHICH REGION IS ANTICIPATED TO WITNESS CONSIDERABLE GROWTH IN THE ENDOSCOPE REPROCESSING MARKET?
4. WHICH PRODUCT IS EXPECTED TO HOLD THE LARGEST SHARE IN THE ENDOSCOPE REPROCESSING MARKET?
The global endoscope reprocessing market is expected to grow at a CAGR of 8.37% during 2022-2027.
Endoscope reprocessing is a multi-step process that involves effective cleaning, disinfection, and sterilization of endoscopy devices and their accessories. The high risk of infections associated with improper sterilization of endoscopes is majorly driving the demand for reprocessing equipment. The endoscope reprocessing market will be flourishing due to a focus on high cleaning standards and mounting pressures for sterilized and disinfected medical devices in hospitals and clinics.
The high usage of endoscopic devices mainly drives the global endoscope reprocessing market for diagnosis and treatment. This is due to the growing burden of various digestive and respiratory tract disorders that require endoscopy. Frequent use of these endoscopic instruments leads to an increased risk of infections; hence, these are being disinfected and cleaned using reprocessing systems. The demand for these systems is likely to grow in healthcare centers, but however, the high cost of endoscopy, improper or under reprocessing leading to infections, and the growing prominence of single-use bio processors can hinder the growth of the market.
Gastrointestinal (GI) endoscopy is an essential tool for identifying and treating gastrointestinal tract disorders. Gastrointestinal endoscopes can become highly contaminated with their frequent use in patients, as millions of endoscopy procedures are being performed in the US alone. Cleaning, disinfection, and sterilization process are vital for the prevention of infections caused due to the contamination of these endoscopes. Hence the demand for reprocessing the endoscopes has become highly important.
MARKET TRENDS & DRIVERS
- The rise in Target Population Requiring Endoscopic Interventions
- Growing Risk of Developing Endoscope-Related Infections
- Regulatory Guidelines Promoting Usage of Endoscope Reprocessing
- Increasing Hospital Investments in Endoscopes & Reprocessing Systems
The number of patients suffering from gastrointestinal diseases is rising across the world. These diseases are among the most costly and debilitating health conditions, accounting for about 3 million hospital admissions in the United States alone. The prevalence of these diseases is increasing the need for performing endoscopic procedures in various healthcare centers. An estimated 17 million lower GI endoscopies and about the same number of upper endoscopies are performed annually in the US. This initiates the risk of infections associated with the formation of biofilms due to their frequent usage. The infection rate approaches 1 in 10 million procedures. With the growing risk of these infections, the demand for endoscope reprocessing systems is growing.
THE GROWING TREND OF INCORPORATING TRACKING SOLUTIONS
Proper endoscope reprocessing is vital for patient safety. Ensuring that every step in the process is completed needs complex tracking and documentation. Eliminating manual documentation logs and ensuring the endoscope is disinfected and cleaned before using it in the procedure. Significant benefits of these tracking solutions include improved handling of endoscope complexity, integration with multiple systems, quality assurance of workflow, and optimization of return on investment.
TECHNOLOGICAL ADVANCEMENTS DRIVING MARKET GROWTH
Several manufacturers are emphasizing automation of the disinfection workflows to a large extent. This has also defined their production advancements and innovation strategies in recent years. For instance, in 2018, around $0.4 billion was invested by Olympus to enhance their systems for performing tests to check cleaning and disinfection effectiveness. The cleaning has always been challenging owing to the inability to inspect the cleanliness inside the lumens of an endoscope until now. The latest technological advancements have allowed the development of flexible inspection camera systems that can check an instrument's internal channels for debris and damage, which could help reduce infection rates.
HIGH COST OF ENDOSCOPY PROCEDURES AND REPROCESSING EQUIPMENT
The high cost associated with endoscopy lowers the number of endoscopic procedures performed on patients. Medical procedures such as endoscopies can be costly without insurance. The cost of a colonoscopy typically ranges between $1,250 to over $4,800 in the US, with an endoscopy's national average price of $2,750. Also, the cost of the equipment ranges from $114.07 to $280.71. The average reported repair cost—whether attributed to a leak test failure, damage during a visual inspection, or a failed cleaning verification test was estimated to be $5,833. Such high prices can limit the adoption of re-processing equipment.
IMPACT OF COVID-19 ON THE GLOBAL ENDOSCOPE REPROCESSING MARKET
Gastrointestinal complaints were frequent among COVID-19 patients, with possible occurrences of diarrhea, nausea, and vomiting. A March 2020 multicenter survey revealed near-universal exposure to COVID-19 positive patients in endoscopy units: 97.6% experienced a reduction in endoscopic activities, and 50% performed endoscopic procedures on COVID-19 positive patients. Hence, there was a moderate need for performing endoscopy procedures during COVID-19. Due to this, the demand for endoscope re-processing systems was high as there was a high risk of disease transmission among patients and healthcare providers.
MARKET SEGMENTATION
PRODUCT
In 2021, disinfectants accounted for the largest share in the global endoscope reprocessing market. The demand for disinfectants is high as there is a growing need for disinfecting endoscopes. By equipment, the market is segmented as automated endoscope reprocessors and disinfection & sterilization equipment. Automated reprocessors accounted for the highest share in the market compared to disinfection & sterilization systems as the demand for automatic reprocessing systems is proliferating owing to their advanced features and better reprocessing.
END-USER
The end-user market includes hospitals, specialty clinics & medical office suites, standalone service facilities, and others. In 2021, hospitals accounted for the highest share of the global endoscopy device cleaning market. The use of endoscopic devices is high ins hospitals as these perform an increased number of endoscopic procedures compared to other healthcare settings. However, standalone reprocessing service facilities will likely witness the fastest growth during the forecast period.
Market Segments
Product:
- Reprocessing Equipment
- Disinfectants
- Detergents
- Drying, Storage & Transport Systems
- Others
- Hospitals
- Specialty Clinics & Medical Office Suites
- Standalone Reprocessing Service Facilities
- Others:
In 2021, North America accounted for the highest share of the global endoscope reprocessing market. Significant factors contributing to the growth of endoscope reprocessing market share in the North America region include a rise in the number of endoscopic procedures performed, high demand for sterilizing and disinfecting endoscopic devices, increasing prevalence of digestive disorders, guidelines promoting safe procedures, and technological advancements in the systems and accessories. However, the APAC region will likely witness the fastest growth during the forecast period.
North America
- US
- Canada
- UK
- France
- Germany
- Italy
- Spain
- Japan
- China
- India
- South Korea
- Australia
- Brazil
- Mexico
- Argentina
- Turkey
- Saudi Arabia
- UAE
- South Africa
The global market is highly competitive, with international, regional, and local players offering a broad range of products and accessories. Leading vendors such as STERIS, Ecolab, Getinge AB, Olympus, and ASP (acquired by Fortive) are coming up with several strategies such as partnerships, collaborations, joint ventures, mergers, and acquisitions for their growth and establishment in the industry.
For instance, STERIS recently agreed to acquire Cantel Medical, a global provider of infection prevention products and services primarily to endoscopy and dental customers.
Ecolab has developed vanBaerle, offering a full range of cleaning, disinfectant, and hygiene solutions, which can contribute to Ecolab's growth in cleaning and disinfectant products.
Product launches from these vendors are advancing the global endoscope reprocessing market. For instance, in 2020, Olympus launched its OER-Elite next-generation automated endoscope reprocessing system.
Key Vendors:
- STERIS
- Ecolab
- Getinge AB
- Olympus
- Fortive
- 3M
- ATMS
- Metall Zug
- BES Healthcare
- CONMED
- Hoya
- CREO Medical
- Medalkan
- Medical Devices
- Metrex Research
- PurposeBuilt
- Richard Wolf
- Summit Imaging
- NanoSonics
- Pentax medical
- Mitra Group
- CENSIS
- Sympliant
- Acuro Organics
- Becto
- Brulin
- Cardinal Health
- Cetylite
- Contec
- Hygiene-Konzepte
- Lonza
- Hako Group
- Pharmax
- The Clorox
1. WHAT IS THE PROJECTED MARKET SIZE & GROWTH RATE OF THE ENDOSCOPE REPROCESSING MARKET?
2. WHAT ARE THE KEY DRIVING FACTORS FOR THE GROWTH OF THE ENDOSCOPE REPROCESSING MARKET?
3. WHICH REGION IS ANTICIPATED TO WITNESS CONSIDERABLE GROWTH IN THE ENDOSCOPE REPROCESSING MARKET?
4. WHICH PRODUCT IS EXPECTED TO HOLD THE LARGEST SHARE IN THE ENDOSCOPE REPROCESSING MARKET?
Table of Contents
298 Pages
- 1 RESEARCH METHODOLOGY
- 2 RESEARCH OBJECTIVES
- 3 RESEARCH PROCESS
- 4 SCOPE & COVERAGE
- 4.1 MARKET DEFINITION
- 4.1.1 INCLUSIONS
- 4.1.2 EXCLUSIONS
- 4.1.3 MARKET ESTIMATION CAVEATS
- 4.2 BASE YEAR
- 4.3 SCOPE OF THE STUDY
- 4.3.1 MARKET SEGMENTATION BY PRODUCT
- 4.3.2 MARKET SEGMENTATION BY END-USER
- 4.3.3 MARKET SEGMENTATION BY GEOGRAPHY
- 5 REPORT ASSUMPTIONS & CAVEATS
- 5.1 KEY CAVEATS
- 5.2 CURRENCY CONVERSION
- 5.3 MARKET DERIVATION
- 6 MARKET AT A GLANCE
- 7 INTRODUCTION
- 7.1 OVERVIEW
- 8 PREMIUM INSIGHTS
- 8.1 OVERVIEW
- 8.1.1 ENDOSCOPE REPROCESSING MARKET
- 8.1.2 ENDOSCOPE REPROCESSING: MARKET SEGMENTATIONS
- 8.1.3 COMPETITIVE SCENARIO
- 9 MARKET OPPORTUNITIES & TRENDS
- 9.1 INCREASED FDA EVALUATIONS & APPROVALS OF AUTOMATED ENDOSCOPE REPROCESSORS
- 9.2 DEMAND FOR ENDOSCOPE REPROCESSING TRACKING SOLUTIONS
- 9.3 TECHNOLOGICAL ADVANCES IN ENDOSCOPE REPROCESSING METHODS
- 10 MARKET GROWTH ENABLERS
- 10.1 INCREASE IN TARGET POPULATION REQUIRING ENDOSCOPIC INTERVENTIONS
- 10.2 RISK OF ENDOSCOPE-RELATED INFECTIONS
- 10.3 REGULATORY GUIDELINES THAT PROMOTE ENDOSCOPE REPROCESSING
- 10.4 HOSPITAL INVESTMENTS IN ENDOSCOPES & RELATED REPROCESSING SYSTEMS
- 11 MARKET RESTRAINTS
- 11.1 HIGH COST OF ENDOSCOPE REPROCESSING EQUIPMENT
- 11.2 SAFETY CONCERNS & LIMITATIONS OF ENDOSCOPE REPROCESSING
- 11.3 SIDE EFFECTS OF DETERGENTS & DISINFECTANTS
- 11.4 GROWTH IN POPULARITY OF SINGLE-USE ENDOSCOPES
- 12 MARKET LANDSCAPE
- 12.1 MARKET OVERVIEW
- 12.2 MARKET SIZE & FORECAST
- 12.2.1 INSIGHTS BY PRODUCT
- 12.2.2 INSIGHTS BY ENDOSCOPE REPROCESSING EQUIPMENT
- 12.2.3 INSIGHTS BY END-USER
- 12.2.4 INSIGHTS BY GEOGRAPHY
- 12.3 FIVE FORCES ANALYSIS
- 12.3.1 THREAT OF NEW ENTRANTS
- 12.3.2 BARGAINING POWER OF SUPPLIERS
- 12.3.3 BARGAINING POWER OF BUYERS
- 12.3.4 THREAT OF SUBSTITUTES
- 12.3.5 COMPETITIVE RIVALRY
- 13 PRODUCT
- 13.1 MARKET SNAPSHOT & GROWTH ENGINE
- 13.2 MARKET OVERVIEW
- 14 DISINFECTANTS
- 14.1 MARKET OVERVIEW
- 14.2 MARKET SIZE & FORECAST
- 14.2.1 DISINFECTANTS: MARKET BY GEOGRAPHY
- 15 REPROCESSING EQUIPMENT
- 15.1 MARKET OVERVIEW
- 15.2 MARKET SIZE & FORECAST
- 15.2.1 REPROCESSING EQUIPMENT: MARKET BY GEOGRAPHY
- 15.3 AUTOMATED ENDOSCOPE REPROCESSORS
- 15.3.1 MARKET OVERVIEW
- 15.3.2 MARKET SIZE & FORECAST
- 15.3.3 AUTOMATED ENDOSCOPE REPROCESSORS: MARKET BY GEOGRAPHY
- 15.4 DISINFECTION & STERILIZATION SYSTEMS
- 15.4.1 MARKET OVERVIEW
- 15.4.2 MARKET SIZE & FORECAST
- 15.4.3 DISINFECTION & STERILIZATION SYSTEMS: MARKET BY GEOGRAPHY
- 16 DETERGENTS
- 16.1 MARKET OVERVIEW
- 16.2 MARKET SIZE & FORECAST
- 16.2.1 DETERGENTS: MARKET BY GEOGRAPHY
- 17 DRYING, STORAGE & TRANSPORT SYSTEMS
- 17.1 MARKET OVERVIEW
- 17.2 MARKET SIZE & FORECAST
- 17.2.1 DRYING STORAGE, & TRANSPORT SYSTEMS: MARKET BY GEOGRAPHY
- 18 OTHERS
- 18.1 MARKET OVERVIEW
- 18.2 MARKET SIZE & FORECAST
- 18.2.1 OTHERS: MARKET BY GEOGRAPHY
- 19 END-USER
- 19.1 MARKET SNAPSHOT & GROWTH ENGINE
- 19.2 MARKET OVERVIEW
- 19.3 HOSPITALS
- 19.3.1 MARKET OVERVIEW
- 19.3.2 MARKET SIZE & FORECAST
- 19.3.3 HOSPITALS: MARKET BY GEOGRAPHY
- 19.4 SPECIALTY CLINICS & MEDICAL OFFICE SUITES
- 19.4.1 MARKET OVERVIEW
- 19.4.2 MARKET SIZE & FORECAST
- 19.4.3 SPECIALTY CLINICS & MEDICAL OFFICE SUITES: MARKET BY GEOGRAPHY
- 19.5 STANDALONE REPROCESSING SERVICE FACILITIES
- 19.5.1 MARKET OVERVIEW
- 19.5.2 MARKET SIZE & FORECAST
- 19.5.3 STANDALONE REPROCESSING SERVICE FACILITIES: MARKET BY GEOGRAPHY
- 19.6 OTHERS
- 19.6.1 MARKET OVERVIEW
- 19.6.2 MARKET SIZE & FORECAST
- 19.6.3 OTHERS: MARKET BY GEOGRAPHY
- 20 GEOGRAPHY
- 20.1 MARKET SNAPSHOT & GROWTH ENGINE
- 20.2 GEOGRAPHIC OVERVIEW
- 21 NORTH AMERICA
- 21.1 MARKET OVERVIEW
- 21.2 MARKET SIZE & FORECAST
- 21.2.1 NORTH AMERICA: PRODUCT
- 21.2.2 NORTH AMERICA: REPROCESSING EQUIPMENT
- 21.2.4 NORTH AMERICA: END-USER
- 21.3 KEY COUNTRIES
- 21.3.1 US: MARKET SIZE & FORECAST
- 21.3.2 CANADA: MARKET SIZE & FORECAST
- 22 EUROPE
- 22.1 MARKET OVERVIEW
- 22.2 MARKET SIZE & FORECAST
- 22.2.1 EUROPE: PRODUCT
- 22.2.2 EUROPE: REPROCESSING EQUIPMENT
- 22.2.4 EUROPE: END-USER
- 22.3 KEY COUNTRIES
- 22.3.1 GERMANY: MARKET SIZE & FORECAST
- 22.3.2 UK: MARKET SIZE & FORECAST
- 22.3.3 FRANCE: MARKET SIZE & FORECAST
- 22.3.4 ITALY: MARKET SIZE & FORECAST
- 22.3.5 SPAIN: MARKET SIZE & FORECAST
- 23 APAC
- 23.1 MARKET OVERVIEW
- 23.2 MARKET SIZE & FORECAST
- 23.2.1 APAC: PRODUCT
- 23.2.2 APAC: REPROCESSING EQUIPMENT
- 23.2.4 APAC: END-USER
- 23.3 KEY COUNTRIES
- 23.3.1 CHINA: MARKET SIZE & FORECAST
- 23.3.2 JAPAN: MARKET SIZE & FORECAST
- 23.3.3 INDIA: MARKET SIZE & FORECAST
- 23.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
- 23.3.5 AUSTRALIA: MARKET SIZE & FORECAST
- 24 LATIN AMERICA
- 24.1 MARKET OVERVIEW
- 24.2 MARKET SIZE & FORECAST
- 24.2.1 LATIN AMERICA: PRODUCT
- 24.2.2 LATIN AMERICA: REPROCESSING EQUIPMENT
- 24.2.4 LATIN AMERICA: END-USER
- 24.3 KEY COUNTRIES
- 24.3.1 BRAZIL: MARKET SIZE & FORECAST
- 24.3.2 MEXICO: MARKET SIZE & FORECAST
- 24.3.3 ARGENTINA: MARKET SIZE & FORECAST
- 25 MIDDLE EAST & AFRICA
- 25.1 MARKET OVERVIEW
- 25.2 MARKET SIZE & FORECAST
- 25.2.1 MIDDLE EAST & AFRICA: PRODUCT
- 25.2.2 MIDDLE EAST & AFRICA: REPROCESSING EQUIPMENT
- 25.2.4 MIDDLE EAST & AFRICA: END-USER
- 25.3 KEY COUNTRIES
- 25.3.1 TURKEY: MARKET SIZE & FORECAST
- 25.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
- 25.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST
- 25.3.4 UAE: MARKET SIZE & FORECAST
- 26 COMPETITIVE LANDSCAPE
- 26.1 COMPETITION OVERVIEW
- 26.2 MARKET SHARE ANALYSIS
- 26.2.1 STERIS
- 26.2.2 ECOLAB
- 26.2.3 GETINGE
- 26.2.4 OLYMPUS
- 26.2.5 FORTIVE
- 27 KEY COMPANY PROFILES
- 27.1 STERIS
- 27.1.1 BUSINESS OVERVIEW
- 27.1.2 PRODUCT OFFERINGS
- 27.1.3 KEY STRATEGIES
- 27.1.4 KEY STRENGTHS
- 27.1.5 KEY OPPORTUNITIES
- 27.2 ECOLAB
- 27.2.1 BUSINESS OVERVIEW
- 27.2.2 PRODUCT OFFERINGS
- 27.2.3 KEY STRATEGIES
- 27.2.4 KEY STRENGTHS
- 27.2.5 KEY OPPORTUNITIES
- 27.3 GETINGE AB
- 27.3.1 BUSINESS OVERVIEW
- 27.3.2 PRODUCT OFFERINGS
- 27.3.3 KEY STRATEGIES
- 27.3.4 KEY STRENGTHS
- 27.3.5 KEY OPPORTUNITIES
- 27.4 OLYMPUS
- 27.4.1 BUSINESS OVERVIEW
- 27.4.2 PRODUCT OFFERINGS
- 27.4.3 KEY STRATEGIES
- 27.4.4 KEY STRENGTHS
- 27.4.5 KEY OPPORTUNITIES
- 27.5 FORTIVE
- 27.5.1 BUSINESS OVERVIEW
- 27.5.2 PRODUCT OFFERINGS
- 27.5.3 KEY STRATEGIES
- 27.5.4 KEY STRENGTHS
- 27.5.5 KEY OPPORTUNITIES
- 28 OTHER PROMINENT VENDORS
- 28.1 3M
- 28.1.1 BUSINESS OVERVIEW
- 28.1.2 PRODUCT OFFERINGS
- 28.2 ACURO ORGANICS LIMITED
- 28.2.1 BUSINESS OVERVIEW
- 28.2.2 PRODUCT OFFERINGS
- 28.3 ATMS
- 28.3.1 BUSINESS OVERVIEW
- 28.3.2 PRODUCT OFFERINGS
- 28.4 BECTO
- 28.4.1 BUSINESS OVERVIEW
- 28.4.2 PRODUCT OFFERINGS
- 28.5 BES HEALTHCARE
- 28.5.1 BUSINESS OVERVIEW
- 28.5.2 PRODUCT OFFERINGS
- 28.6 BRULIN
- 28.6.1 BUSINESS OVERVIEW
- 28.6.2 PRODUCT OFFERINGS
- 28.7 CARDINAL HEALTH
- 28.7.1 BUSINESS OVERVIEW
- 28.7.2 PRODUCT OFFERINGS
- 28.8 CENSIS
- 28.8.1 BUSINESS OVERVIEW
- 28.8.2 PRODUCT OFFERINGS
- 28.9 CETYLITE
- 28.9.1 BUSINESS OVERVIEW
- 28.9.2 PRODUCT OFFERINGS
- 28.10 CONMED
- 28.10.1 BUSINESS OVERVIEW
- 28.10.2 PRODUCT OFFERINGS
- 28.11 CONTEC
- 28.11.1 BUSINESS OVERVIEW
- 28.11.2 PRODUCT OFFERINGS
- 28.12 CREO MEDICAL
- 28.12.1 BUSINESS OVERVIEW
- 28.12.2 PRODUCT OFFERINGS
- 28.13 HAKO GROUP
- 28.13.1 BUSINESS OVERVIEW
- 28.13.2 PRODUCT OFFERINGS
- 28.14 HOYA
- 28.14.1 BUSINESS OVERVIEW
- 28.14.2 PRODUCT OFFERINGS
- 28.15 HYGIENE-KONZEPTE
- 28.15.1 BUSINESS OVERVIEW
- 28.15.2 PRODUCT OFFERINGS
- 28.16 LONZA
- 28.16.1 BUSINESS OVERVIEW
- 28.16.2 PRODUCT OFFERINGS
- 28.17 MEDALKAN
- 28.17.1 BUSINESS OVERVIEW
- 28.17.2 PRODUCT OFFERINGS
- 28.18 MEDICAL DEVICES GROUP SRL
- 28.18.1 BUSINESS OVERVIEW
- 28.18.2 PRODUCT OFFERINGS
- 28.19 METALL ZUG AG
- 28.19.1 BUSINESS OVERVIEW
- 28.19.2 PRODUCT OFFERINGS
- 28.20 METREX RESEARCH
- 28.20.1 BUSINESS OVERVIEW
- 28.20.2 PRODUCT OFFERINGS
- 28.21 MITRA GROUP
- 28.21.1 BUSINESS OVERVIEW
- 28.21.2 PRODUCT OFFERINGS
- 28.22 NANOSONICS
- 28.22.1 BUSINESS OVERVIEW
- 28.22.2 PRODUCT OFFERINGS
- 28.23 PENTAX MEDICAL
- 28.23.1 BUSINESS OVERVIEW
- 28.23.2 PRODUCT OFFERINGS
- 28.24 PHARMAX
- 28.24.1 BUSINESS OVERVIEW
- 28.24.2 PRODUCT OFFERINGS
- 28.25 PURPOSEBUILT BRANDS
- 28.25.1 BUSINESS OVERVIEW
- 28.25.2 PRODUCT OFFERINGS
- 28.26 RICHARD WOLF GMBH
- 28.26.1 BUSINESS OVERVIEW
- 28.26.2 PRODUCT OFFERINGS
- 28.27 SUMMIT IMAGING
- 28.27.1 BUSINESS OVERVIEW
- 28.27.2 PRODUCT OFFERINGS
- 28.28 SYMPLIANT
- 28.28.1 BUSINESS OVERVIEW
- 28.28.2 PRODUCT OFFERINGS
- 28.29 THE CLOROX COMPANY
- 28.29.1 BUSINESS OVERVIEW
- 28.29.2 PRODUCT OFFERINGS
- 28.30 TUTTNAUER
- 28.30.1 BUSINESS OVERVIEW
- 28.30.2 PRODUCT OFFERINGS
- 29 REPORT SUMMARY
- 29.1 KEY TAKEAWAYS
- 29.2 STRATEGIC RECOMMENDATIONS
- 30 QUANTITATIVE SUMMARY
- 30.1 MARKET BY PRODUCT
- 30.1.1 NORTH AMERICA: PRODUCT SEGMENTATION
- 30.1.2 EUROPE: PRODUCT SEGMENTATION
- 30.1.3 APAC: PRODUCT SEGMENTATION
- 30.1.4 LATIN AMERICA: PRODUCT SEGMENTATION
- 30.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
- 30.2 MARKET BY REPROCESSING EQUIPMENT
- 30.2.1 NORTH AMERICA: REPROCESSING EQUIPMENT SEGMENTATION
- 30.2.2 EUROPE: REPROCESSING EQUIPMENT SEGMENTATION
- 30.2.3 APAC: REPROCESSING EQUIPMENT SEGMENTATION
- 30.2.4 LATIN AMERICA: REPROCESSING EQUIPMENT SEGMENTATION
- 30.2.5 MIDDLE EAST & AFRICA: REPROCESSING EQUIPMENT SEGMENTATION
- 30.3 MARKET BY END-USER
- 30.3.1 NORTH AMERICA: END-USER SEGMENTATION
- 30.3.2 EUROPE: END-USER SEGMENTATION
- 30.3.3 APAC: END-USER SEGMENTATION
- 30.3.4 LATIN AMERICA: END-USER SEGMENTATION
- 30.3.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
- 30.4 MARKET BY GEOGRAPHY
- 30.4.1 DISINFECTANTS: GEOGRAPHY SEGMENTATION
- 30.4.2 REPROCESSING EQUIPMENT: GEOGRAPHY SEGMENTATION
- 30.4.3 DETERGENTS: GEOGRAPHY SEGMENTATION
- 30.4.4 DRYING, STORAGE, & TRANSPORT SYSTEMS: GEOGRAPHY SEGMENTATION
- 30.4.5 OTHERS: GEOGRAPHY SEGMENTATION
- 30.4.6 AUTOMATED ENDOSCOPE REPROCESSORS: GEOGRAPHY SEGMENTATION
- 30.4.7 DISINFECTION & STERILIZATION SYSTEMS: GEOGRAPHY SEGMENTATION
- 30.4.8 HOSPITALS: GEOGRAPHY SEGMENTATION
- 30.4.9 SPECIALTY CLINICS & MEDICAL OFFICE SUITES: GEOGRAPHY SEGMENTATION
- 30.4.10 STANDALONE REPROCESSING SERVICE FACILITIES: GEOGRAPHY SEGMENTATION
- 30.4.11 OTHERS: GEOGRAPHY SEGMENTATION
- 31 APPENDIX
- 31.1 ABBREVIATIONS
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
